mediKOL Ltd.

mediKOL provides clients in the pharmaceutical and associated industries with high-quality commercial analysis, underpinned by the experience and views of some of the world’s most respected key opinion leaders (KOLs) and allied experts. With over 50 years analytical and consulting experience we have developed an extensive network of KOL and specialist contacts, together with the analytical experience and commercial knowledge required to develop these views into commercially valuable insights. mediKOL’s principal product is mediKOL Insight - a range of readily-accessible reports providing high-quality commercial analysis, underpinned by the views and opinions of our panels of experts. Each mediKOL Insight report is also supported by market data and consensus forecasts supplied under license from EvaluatePharma®.

Where Next for Thrombosis? 8/1/2009 \| published by: mediKOL Ltd. ... What are the future scenarios? With so many drugs in development, will it turn into another large cardiovascular ‘me-too’ market? Or, will one drug dominate? Can warfarin be replaced? As one KOL put it, “It’s ... \| more... Search inside this report	$13,500.00
mediKOL Insight: Where next for MS? 12/1/2008 \| published by: mediKOL Ltd. ... This report provides an in-depth and insightful appraisal of the current and future MS market. It is driven principally by the views of a panel of internationally recognised key opinion leaders (KOLs), whose opinions on ... \| more... Search inside this report	$7,500.00